Cargando…
Chemotherapy Response Score in Ovarian Cancer Patients: An Overview of Its Clinical Utility
The chemotherapy response score has been developed over the last few years as a predictive index of survival outcomes for patients with advanced-stage epithelial ovarian cancer undergoing interval debulking surgery. While its importance in predicting patients at risk of developing recurrences earlie...
Autores principales: | Rodolakis, Ioannis, Pergialiotis, Vasilios, Liontos, Michalis, Haidopoulos, Dimitrios, Loutradis, Dimitrios, Rodolakis, Alexandros, Bamias, Aristotelis, Thomakos, Nikolaos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054535/ https://www.ncbi.nlm.nih.gov/pubmed/36983157 http://dx.doi.org/10.3390/jcm12062155 |
Ejemplares similares
-
Is There a Survival Benefit of Adjuvant Chemotherapy in Stage IC1 Epithelial Ovarian Cancer Patients? A Meta-Analysis
por: Pergialiotis, Vasilios, et al.
Publicado: (2022) -
Factors That Affect Survival Outcomes in Patients with Endometrial Clear Cell Carcinoma
por: Pergialiotis, Vasilios, et al.
Publicado: (2022) -
Identification and Biopsy of Sentinel Lymph Node in Early-Stage Cervical Carcinoma: Diagnostic Accuracy and Clinical Utility
por: Koutroumpa, Ioanna, et al.
Publicado: (2022) -
Management of the Elderly Patients with High-Grade Serous Ovarian Cancer in the REAL-WORLD Setting
por: Liontos, Michalis, et al.
Publicado: (2021) -
Survival outcomes of patients with cervical cancer and accompanying hydronephrosis: A systematic review of the literature
por: Pergialiotis, Vasilios, et al.
Publicado: (2019)